1. Home
  2. ARQT vs TGNA Comparison

ARQT vs TGNA Comparison

Compare ARQT & TGNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$28.22

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo TEGNA Inc

TGNA

TEGNA Inc

HOLD

Current Price

$18.92

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
TGNA
Founded
2016
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ARQT
TGNA
Price
$28.22
$18.92
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$24.83
$20.00
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
2.62%
EPS Growth
N/A
N/A
EPS
N/A
2.10
Revenue
$317,929,000.00
$2,876,414,000.00
Revenue This Year
$85.51
N/A
Revenue Next Year
$30.74
$11.10
P/E Ratio
N/A
$9.08
Revenue Growth
129.21
N/A
52 Week Low
$11.13
$14.87
52 Week High
$31.77
$21.35

Technical Indicators

Market Signals
Indicator
ARQT
TGNA
Relative Strength Index (RSI) 46.52 30.54
Support Level $28.75 $19.31
Resistance Level $30.60 $19.40
Average True Range (ATR) 1.31 0.17
MACD -0.14 -0.03
Stochastic Oscillator 15.13 2.82

Price Performance

Historical Comparison
ARQT
TGNA

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About TGNA TEGNA Inc

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

Share on Social Networks: